作者
Nora E. Wessendorf

Dr. Nora E. Wessendorf, LL.M. (Washington)

授薪合伙人

Read More
作者
Nora E. Wessendorf

Dr. Nora E. Wessendorf, LL.M. (Washington)

授薪合伙人

Read More

2023年9月21日

Patenting AI-generated inventions – is patent law acting the luddite?

  • Briefing
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

UPC

The first 100 days of the UPC from a life sciences perspective – a very good message

2023年9月20日
Quick read

作者 Dr. Anja Lunze, LL.M. 以及 Dr. Nora E. Wessendorf, LL.M. (Washington)

点击此处了解更多
酒店与休闲

New Competition Rules for R&D Cooperation Agreements

2023年3月30日
In-depth analysis

作者 Stephan Manuel Nagel, LL.M. (EUI) 以及 Dr. Nora E. Wessendorf, LL.M. (Washington)

点击此处了解更多
酒店与休闲

Does a clinical trial render the pharmaceutical formulation used therein public?

2023年3月29日
Briefing

作者 Dr. Nora E. Wessendorf, LL.M. (Washington)

点击此处了解更多